On December 28, 2023, Abion Inc. closed the transaction
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,100 KRW | -2.05% | -0.96% | -50.16% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
8,270 KRW | +0.85% | +8.96% | 133M | ||
3,100 KRW | -2.05% | -0.96% | 32.75M | ||
824 KRW | +1.10% | +3.13% | 67.42M | ||
1st Jan change | Capi. | |
---|---|---|
-50.16% | 32.75M | |
-4.62% | 12.37B | |
-1.48% | 8.37B | |
+10.20% | 5.84B | |
+25.61% | 5.4B | |
-4.58% | 4.37B | |
-51.80% | 3.23B | |
+16.25% | 2.8B | |
+30.25% | 2.26B | |
-9.24% | 2.22B |
- Stock Market
- Equities
- A229000 Stock
- News Gencurix Inc.
- Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.